We found that exposure to maternal CRMP1+CRMP2 autoantibodies elicits the strongest DE response with over 1390 DE genes passing FDR < 0.1, which aligns with our clinical observation that CRMP1+CRMP2 is associated with a more severe autism phenotype [12, 13]. The gene discussed is DPYSL2; the disease is autism.